Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24 + glioma patients

Oncology Reports

Volumn 17, Issue 3, 2007, Pages 629-636

  Harada, Mamoru ^a,b   Ishihara, Yuki ^a   Itoh, Kyogo ^a   Yamanaka, Ryuya ^a,c  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocyte; Glioma; Human leukocyte antigen A24; Kinesin; Peptide

Indexed keywords

CANCER VACCINE; HLA A ANTIGEN; HLA A24 ANTIGEN; IMMUNOGLOBULIN G; KINESIN; MESSENGER RNA; PEPTIDE; TUMOR ANTIGEN;

ARTICLE; BLOOD; BRAIN TUMOR; CYTOTOXIC T LYMPHOCYTE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CANCER VACCINES; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; HLA-A ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; KINESIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34247854935     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.3.629     Document Type: Article

References (30)

1. Karpeh MS, Kelsen DP and Tepper JE: Cancer of the stomach. In: Cancer: Principles and Practice of Oncology. Devita VT Jr (ed). 6th edition. Lippincott Williams & Wilkins, Philadelphia, pp1092-1121, 2001.
2. Stewart LA: Chemotherapy in adult high-grade glioma: s systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018, 2002.
3. Renkvist N, Castelli C, Robbins PF and Parmiani G: A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50: 3-15, 2001. (Pubitemid 32250041)
4. Liu G, Ying H, Zeng G, Wheeler CJ, Black KL and Yu JS: HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res 64: 4980-4986, 2000. (Pubitemid 38924546)
5. Murayama K, Kobayashi T, Imaizumi T, et al: Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides. J Immunother 23: 511-518, 2000.
6. Tsuda N, Nonaka Y, Shichijo S, et al: UDP-Gal: bGlcNAc b1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumours. Br J Cancer 87: 1006-1012, 2002. (Pubitemid 35305654)
7. Okabe H, Satoh S, Kato T, et al: Genome-wide analysis of gene expression in human hepatocellular carcinoma using cDNA microarray: identification of genes involving in viral carcinogenesis and tumor progression. Cancer Res 61: 2129-2137, 2001. (Pubitemid 32692038)
8. Hasegawa S, Furukawa Y, Li M, et al: Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62: 7012-7017, 2002. (Pubitemid 35424095)
9. Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002. (Pubitemid 34212595)
10. Yamanaka R, Arao T, Yajima N, et al: Indentification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 25: 5994-6002, 2006. (Pubitemid 44477293)
11. Komatsu N, Shichijo S, Nakagawa M and Itoh K: New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 64: 1-11, 2004.
12. Hida N, Maeda Y, Katagiri K, Takasu H, Harada M and Itoh K: A new culture protocol to detect peptide-specific cytotixic T lymphocyte precursors in the circulation. Cancer Immunol Immunother 51: 219-228, 2002. (Pubitemid 34493956)
13. Parker KC, Bednarek MA and Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175, 1994.
14. Nakatsura T, Senju S, Ito M, Nishimura Y and Itoh K: Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur J Immunol 32: 826-836, 2002. (Pubitemid 34257560)
15. Mine T, Sato Y, Noguchi M, et al: Humoral responses to peptides correlated with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses. Clin Cancer Res 10: 929-937, 2004. (Pubitemid 38198892)
16. Yajima N, Yamanaka R, Mine T, et al: Immunological evaluation of personalized peptide vaccination for patients with advanced malignant glioma. Clin Cancer Res 11: 5900-5911, 2005. (Pubitemid 41170319)
17. Miki H, Setou M, Kaneshiro K and Hirokawa N: All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci USA 98: 7004-7011, 2001. (Pubitemid 32567894)
18. Vallee RB and Sheetz MP: Targeting of motor proteins. Science 271: 1539-1544, 1996. (Pubitemid 26097213)
19. Funk CJ, Davis AS, Hopkins JA and Middleton KM: Development of high-throughput screens for discovery of kinesin adenosine triphosphatase modulators. Anal Biochem 329: 68-76, 2004. (Pubitemid 38596902)
20. Katayama H, Brinkley WR and Sen S: The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22: 451-464, 2003. (Pubitemid 36791899)
21. Marmorstein LY, Kinev AV, Chan KG, et al: A human BRCA2 complexes containing a structural DNA binding component influences cell cycle progression. Cell 26: 247-257, 2001. (Pubitemid 32174840)
22. Sakowicz R, Finer JT, Beraud C, et al: Antitumor activity of a kinesin inhibitor. Cancer Res 64: 3276-3280, 2004. (Pubitemid 38581433)
23. Marcus AI, Peter U, Thomas SL, et al: Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells. J Biol Chem 280: 11569-11577, 2005. (Pubitemid 40418469)
24. Dorner C, Ciossek T, Muller S, Moller PH, Ullrich A and Lammers R: Characterization of KIF1C, a new kinesin-like protein involved in vesicle transport from the Golgi apparatus to the endoplasmic reticulum. J Biol Chem 273: 20267-20275, 1998. (Pubitemid 28377589)
25. Muresan V, Abramson T, Lyass A, et al: KIF3C and KIF3A form a novel neuronal heteromeric kinesin that associates with membrane vesicles. Mol Biol Cell 9: 637-652, 1998. (Pubitemid 28125622)
26. Navone F, Consalez GG, Sardella M, et al: Expression of KIF3C kinesin during neural development and in vitro neuronal differentiation. J Neurochem 77: 741-753, 2001. (Pubitemid 32466772)
27. Marszalek JR, Weiner JA, Farlow SJ, Chun J and Goldstein LS: Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B. J Cell Biol 145: 469-479, 1999. (Pubitemid 29215712)
28. Shichijo S, Ito M, Azuma K, et al: A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognized by cytotoxic T lymphocytes from HLA- A2+colon cancer patients. Eur J Cancer 41: 1323-1330, 2005. (Pubitemid 40813010)
29. Ogata R, Matsueda S, Yao A, Noguchi M, Itoh K and Harada M: Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+prostate cancer patients. Prostate 60: 273-281, 2004. (Pubitemid 39050645)
30. Matsueda S, Takedatsu H, Yao A, Noguchi M, Itoh K and Harada M: Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles. Clin Cancer Res 11: 6933-6943, 2005. (Pubitemid 41428751) Technology Technology Technology